Compound Detail
CHEMBL2376158
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
C[C@@H](NC(=O)c1c[nH]c2ncc(-c3ncn4cc(F)cc(F)c34)nc12)C(=O)N1CC(C#N)C1
Basic Information
| ChEMBL ID | CHEMBL2376158 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XVOQZCVSDBIDJD-SNVBAGLBSA-N |
5
Targets
6
Activities
1
Assay Types
0
PK Parameters
20
Publications
0
Known Names
Molecular Properties
450.4
MW (Da)
1.65
ALogP
7
HBA
2
HBD
132.1
PSA (Ų)
0.49
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 9.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK3 CHEMBL2148 | IC50 | 9.0 | 9.0 | 1.0 | 1 |
| Tyrosine-protein kinase JAK2 CHEMBL2971 | IC50 | 7.43 | 6.2 | 37.0 | 2 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | IC50 | 7.14 | 7.14 | 73.0 | 1 |
| JAK3/JAK1 CHEMBL3038491 | IC50 | 5.89 | 5.89 | 1290.0 | 1 |
| JAK2/JAK1 CHEMBL3038492 | IC50 | 4.89 | 4.89 | 12900.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK3 | IC50 | = | 1.0 | nM | 9.0 | Inhibition of JAK3 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVK... | 23540648 |
| Tyrosine-protein kinase JAK2 | IC50 | = | 37.0 | nM | 7.43 | Inhibition of JAK2 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVK... | 23540648 |
| Tyrosine-protein kinase JAK1 | IC50 | = | 73.0 | nM | 7.14 | Inhibition of JAK1 (unknown origin) using [33gammaP]ATP and Biotin-KAIETDKEYYTVK... | 23540648 |
| JAK3/JAK1 | IC50 | = | 1290.0 | nM | 5.89 | Inhibition of JAK3/1 in human T cells expressing CD3 assessed as inhibition of I... | 23540648 |
| Tyrosine-protein kinase JAK2 | IC50 | = | 10800.0 | nM | 4.97 | Inhibition of JAK2 in human monocytes expressing CD14 assessed as inhibition of ... | 23540648 |
| JAK2/JAK1 | IC50 | = | 12900.0 | nM | 4.89 | Inhibition of JAK2/1 in human T cells expressing CD3 assessed as inhibition of I... | 23540648 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Unchecked | 9 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Tyrosine-protein kinase JAK2 | 2 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Serine/threonine-protein kinase pim-2 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Tyrosine-protein kinase JAK3 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Tyrosine-protein kinase Lck | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Tyrosine-protein kinase Lyn | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Serine/threonine-protein kinase MARK1 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Hepatocyte growth factor receptor | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Ribosomal protein S6 kinase alpha-5 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Serine/threonine-protein kinase 3 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Mitogen-activated protein kinase 14 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Serine/threonine-protein kinase PAK 2 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Tyrosine-protein kinase SYK | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Protein kinase C beta type | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Protein kinase C zeta type | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Serine/threonine-protein kinase D2 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | MAP kinase-activated protein kinase 5 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Rho-associated protein kinase 2 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Ribosomal protein S6 kinase alpha-1 | 1 |
| 23540648 | 10.1016/j.bmcl.2013.02.012 | Serine/threonine-protein kinase Sgk1 | 1 |
Data from ChEMBL 36 via Core Engine